Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
Ray, K. K., Colhoun, H. M., Szarek, P., ... Reiner, Ž., Peršić, V. & Tomulić, V. (2019). Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. The Lancet Diabetes & Endocrinology, 7. (8), 618-628. doi: 10.1016/S2213-8587(19)30158-5
Ray, Kausik K, et al. "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial." The Lancet Diabetes & Endocrinology, vol. 7, no. 8, 2019, pp. 618-628. https://doi.org/10.1016/S2213-8587(19)30158-5
Ray, Kausik K, Helen M Colhoun, Pećin Szarek, Željko ... Reiner, Viktor Peršić and Vjekoslav Tomulić. "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial." The Lancet Diabetes & Endocrinology 7, no. 8 (2019): 618-628. https://doi.org/10.1016/S2213-8587(19)30158-5
Ray, K. K., et al. (2019) 'Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial', The Lancet Diabetes & Endocrinology, 7(8), pp. 618-628. doi: 10.1016/S2213-8587(19)30158-5
Ray KK, Colhoun HM, Szarek P, ... Reiner Ž, Peršić V, Tomulić V. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. The Lancet Diabetes & Endocrinology [Internet]. 2019 August [cited 2025 February 26];7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5
K. K. Ray, H. M. Colhoun, P. Szarek, Ž. ... Reiner, V. Peršić and V. Tomulić, "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial", The Lancet Diabetes & Endocrinology, vol. 7, no. 8, pp. 618-628, August 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:611502. [Accessed: 26 February 2025]